These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
553 related articles for article (PubMed ID: 29413083)
1. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? Wolters PJ; Blackwell TS; Eickelberg O; Loyd JE; Kaminski N; Jenkins G; Maher TM; Molina-Molina M; Noble PW; Raghu G; Richeldi L; Schwarz MI; Selman M; Wuyts WA; Schwartz DA Lancet Respir Med; 2018 Feb; 6(2):154-160. PubMed ID: 29413083 [TBL] [Abstract][Full Text] [Related]
2. Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis. Gajjala PR; Singh P; Odayar V; Ediga HH; McCormack FX; Madala SK Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769178 [TBL] [Abstract][Full Text] [Related]
3. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis. Selman M; Pardo A Cell Signal; 2020 Feb; 66():109482. PubMed ID: 31760172 [TBL] [Abstract][Full Text] [Related]
4. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis. Pardo A; Selman M Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427 [TBL] [Abstract][Full Text] [Related]
6. Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis. Yamaguchi M; Hirai S; Tanaka Y; Sumi T; Miyajima M; Mishina T; Yamada G; Otsuka M; Hasegawa T; Kojima T; Niki T; Watanabe A; Takahashi H; Sakuma Y Lab Invest; 2017 Mar; 97(3):232-242. PubMed ID: 27941755 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis. Geng J; Huang X; Li Y; Xu X; Li S; Jiang D; Liang J; Jiang D; Wang C; Dai H Respir Res; 2015 Oct; 16():124. PubMed ID: 26453058 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis. Gan H; McKenzie R; Hao Q; Idell S; Tang H PLoS One; 2014; 9(7):e101983. PubMed ID: 25000413 [TBL] [Abstract][Full Text] [Related]
9. Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). Confalonieri P; Volpe MC; Jacob J; Maiocchi S; Salton F; Ruaro B; Confalonieri M; Braga L Cells; 2022 Jun; 11(13):. PubMed ID: 35805179 [TBL] [Abstract][Full Text] [Related]
10. Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis. Lee JS; La J; Aziz S; Dobrinskikh E; Brownell R; Jones KD; Achtar-Zadeh N; Green G; Elicker BM; Golden JA; Matthay MA; Kukreja J; Schwartz DA; Wolters PJ Histopathology; 2021 Jul; 79(1):67-76. PubMed ID: 33432658 [TBL] [Abstract][Full Text] [Related]
12. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions. Xu X; Dai H; Wang C Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066 [TBL] [Abstract][Full Text] [Related]
13. The JAK2 pathway is activated in idiopathic pulmonary fibrosis. Milara J; Hernandez G; Ballester B; Morell A; Roger I; Montero P; Escrivá J; Lloris JM; Molina-Molina M; Morcillo E; Cortijo J Respir Res; 2018 Feb; 19(1):24. PubMed ID: 29409529 [TBL] [Abstract][Full Text] [Related]
14. Cell senescence and fibrotic lung diseases. Liu RM; Liu G Exp Gerontol; 2020 Apr; 132():110836. PubMed ID: 31958492 [TBL] [Abstract][Full Text] [Related]
15. Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model. Schruf E; Schroeder V; Le HQ; Schönberger T; Raedel D; Stewart EL; Fundel-Clemens K; Bluhmki T; Weigle S; Schuler M; Thomas MJ; Heilker R; Webster MJ; Dass M; Frick M; Stierstorfer B; Quast K; Garnett JP FASEB J; 2020 Jun; 34(6):7825-7846. PubMed ID: 32297676 [TBL] [Abstract][Full Text] [Related]
16. WNT7B in fibroblastic foci of idiopathic pulmonary fibrosis. Meuten T; Hickey A; Franklin K; Grossi B; Tobias J; Newman DR; Jennings SH; Correa M; Sannes PL Respir Res; 2012 Jul; 13(1):62. PubMed ID: 22838404 [TBL] [Abstract][Full Text] [Related]
17. Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis. Nakahara Y; Hashimoto N; Sakamoto K; Enomoto A; Adams TS; Yokoi T; Omote N; Poli S; Ando A; Wakahara K; Suzuki A; Inoue M; Hara A; Mizutani Y; Imaizumi K; Kawabe T; Rosas IO; Takahashi M; Kaminski N; Hasegawa Y Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34049947 [TBL] [Abstract][Full Text] [Related]
19. A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis. Zhao T; Gong B; Luo S; Zhang R; Zhang L; Huang Y; Gao H; Gong T Acta Biomater; 2023 Sep; 167():574-582. PubMed ID: 37356783 [TBL] [Abstract][Full Text] [Related]
20. Pathologic Criteria for the Diagnosis of Usual Interstitial Pneumonia vs Fibrotic Hypersensitivity Pneumonitis in Transbronchial Cryobiopsies. Churg A; Tazelaar H; Matej R; Vasakova MK; Stewart B; Patel D; Duarte E; Gomez Manjarres DC; Mehta HJ; Wright JL Mod Pathol; 2023 Sep; 36(9):100221. PubMed ID: 37236510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]